chr4-144120558-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002099.8(GYPA):c.68C>A(p.Thr23Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000305 in 1,244,962 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_002099.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYPA | NM_002099.8 | c.68C>A | p.Thr23Asn | missense_variant | 2/7 | ENST00000641688.3 | NP_002090.4 | |
LOC105377460 | XR_002959803.2 | n.5270+5329G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYPA | ENST00000641688.3 | c.68C>A | p.Thr23Asn | missense_variant | 2/7 | NM_002099.8 | ENSP00000493142 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000613 AC: 8AN: 130534Hom.: 0 Cov.: 20
GnomAD3 exomes AF: 0.000111 AC: 20AN: 180324Hom.: 6 AF XY: 0.000134 AC XY: 13AN XY: 96832
GnomAD4 exome AF: 0.0000269 AC: 30AN: 1114428Hom.: 2 Cov.: 29 AF XY: 0.0000269 AC XY: 15AN XY: 557994
GnomAD4 genome AF: 0.0000613 AC: 8AN: 130534Hom.: 0 Cov.: 20 AF XY: 0.0000796 AC XY: 5AN XY: 62794
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | The c.68C>A (p.T23N) alteration is located in exon 2 (coding exon 2) of the GYPA gene. This alteration results from a C to A substitution at nucleotide position 68, causing the threonine (T) at amino acid position 23 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at